Skip to main content
Publication date
2017 Sep
Authors
Lie, E Lindstrom, U Zverkova-Sandstrom, T Olsen, IC Forsblad-d'Elia, H Askling, J Kapetanovic, MC Kristensen, LE Jacobsson, LTH
Author KI Usernames
Askling, J|johask
Pubmed ID
28254789
Journal
Annals of the rheumatic diseases
Doctype
Article
KI Connection
Medel
Mesh SV
Adalimumab Ankyloserande spondylit Antireumatiska medel Behandlingsresultat Etanercept Infliximab Kvinnlig Manlig Medelålders personer Människa Proportional hazard-modeller Register Sverige Tumörnekrosfaktor-alfa Uveit, främre Vuxna
Mesh EN
Adalimumab Antirheumatic Agents Etanercept Infliximab Proportional Hazards Models Registries Spondylitis, Ankylosing Sweden Treatment Outcome Tumor Necrosis Factor-alpha Uveitis, Anterior
First date
2017-09-03T10:13:37.473Z